Evrofarma (Greece) Technical Analysis
| EVROF Stock | EUR 3.71 0.05 1.33% |
As of the 28th of January, Evrofarma shows the Downside Deviation of 1.9, coefficient of variation of 390.88, and Mean Deviation of 1.76. Evrofarma SA technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Evrofarma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Evrofarma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EvrofarmaEvrofarma |
Evrofarma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evrofarma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evrofarma.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Evrofarma on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Evrofarma SA or generate 0.0% return on investment in Evrofarma over 90 days. Evrofarma is related to or competes with Kri Kri, Frigoglass SAIC, Iktinos Hellas, Ellaktor, and Admie Holding. It offers milk and liquids, ayran, cheese and organic cheese, and yogurt More
Evrofarma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evrofarma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evrofarma SA upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.9 | |||
| Information Ratio | 0.2222 | |||
| Maximum Drawdown | 13.07 | |||
| Value At Risk | (2.57) | |||
| Potential Upside | 5.4 |
Evrofarma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evrofarma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evrofarma's standard deviation. In reality, there are many statistical measures that can use Evrofarma historical prices to predict the future Evrofarma's volatility.| Risk Adjusted Performance | 0.1951 | |||
| Jensen Alpha | 0.5921 | |||
| Total Risk Alpha | 0.3711 | |||
| Sortino Ratio | 0.275 | |||
| Treynor Ratio | 71.41 |
Evrofarma January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1951 | |||
| Market Risk Adjusted Performance | 71.42 | |||
| Mean Deviation | 1.76 | |||
| Semi Deviation | 1.29 | |||
| Downside Deviation | 1.9 | |||
| Coefficient Of Variation | 390.88 | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.55 | |||
| Information Ratio | 0.2222 | |||
| Jensen Alpha | 0.5921 | |||
| Total Risk Alpha | 0.3711 | |||
| Sortino Ratio | 0.275 | |||
| Treynor Ratio | 71.41 | |||
| Maximum Drawdown | 13.07 | |||
| Value At Risk | (2.57) | |||
| Potential Upside | 5.4 | |||
| Downside Variance | 3.62 | |||
| Semi Variance | 1.66 | |||
| Expected Short fall | (2.56) | |||
| Skewness | 0.4506 | |||
| Kurtosis | 1.02 |
Evrofarma SA Backtested Returns
Evrofarma appears to be slightly risky, given 3 months investment horizon. Evrofarma SA secures Sharpe Ratio (or Efficiency) of 0.23, which denotes the company had a 0.23 % return per unit of risk over the last 3 months. By reviewing Evrofarma's technical indicators, you can evaluate if the expected return of 0.55% is justified by implied risk. Please utilize Evrofarma's Mean Deviation of 1.76, coefficient of variation of 390.88, and Downside Deviation of 1.9 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Evrofarma holds a performance score of 18. The firm shows a Beta (market volatility) of 0.0083, which means not very significant fluctuations relative to the market. As returns on the market increase, Evrofarma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evrofarma is expected to be smaller as well. Please check Evrofarma's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Evrofarma's price patterns will revert.
Auto-correlation | 0.73 |
Good predictability
Evrofarma SA has good predictability. Overlapping area represents the amount of predictability between Evrofarma time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evrofarma SA price movement. The serial correlation of 0.73 indicates that around 73.0% of current Evrofarma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.73 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Evrofarma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Evrofarma SA Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Evrofarma SA across different markets.
About Evrofarma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Evrofarma SA on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Evrofarma SA based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Evrofarma SA price pattern first instead of the macroeconomic environment surrounding Evrofarma SA. By analyzing Evrofarma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Evrofarma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Evrofarma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Evrofarma January 28, 2026 Technical Indicators
Most technical analysis of Evrofarma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Evrofarma from various momentum indicators to cycle indicators. When you analyze Evrofarma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1951 | |||
| Market Risk Adjusted Performance | 71.42 | |||
| Mean Deviation | 1.76 | |||
| Semi Deviation | 1.29 | |||
| Downside Deviation | 1.9 | |||
| Coefficient Of Variation | 390.88 | |||
| Standard Deviation | 2.36 | |||
| Variance | 5.55 | |||
| Information Ratio | 0.2222 | |||
| Jensen Alpha | 0.5921 | |||
| Total Risk Alpha | 0.3711 | |||
| Sortino Ratio | 0.275 | |||
| Treynor Ratio | 71.41 | |||
| Maximum Drawdown | 13.07 | |||
| Value At Risk | (2.57) | |||
| Potential Upside | 5.4 | |||
| Downside Variance | 3.62 | |||
| Semi Variance | 1.66 | |||
| Expected Short fall | (2.56) | |||
| Skewness | 0.4506 | |||
| Kurtosis | 1.02 |
Evrofarma January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Evrofarma stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1.54 | ||
| Daily Balance Of Power | (0.83) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 3.68 | ||
| Day Typical Price | 3.69 | ||
| Price Action Indicator | 0.01 | ||
| Market Facilitation Index | 0.0006 |
Complementary Tools for Evrofarma Stock analysis
When running Evrofarma's price analysis, check to measure Evrofarma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evrofarma is operating at the current time. Most of Evrofarma's value examination focuses on studying past and present price action to predict the probability of Evrofarma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evrofarma's price. Additionally, you may evaluate how the addition of Evrofarma to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |